A process for preparing tetrakis borate is described that involves reaction of a pentafluorophenyl magnesium halide with an alkali metal tetrafluoroborate. This is particularly a problem during surgical procedures performed within a closed organ, such as the eye. The active component can be delivered to a site of treatment by being carried on a device, such as a stent.